Related Experiment Videos
Medulloblastoma in childhood. Multidisciplinary treatment
Insights
This study on pediatric medulloblastoma found that radical tumor resection significantly improved patient prognosis. Lower-dose radiotherapy reduced side effects, while combination chemotherapy was more effective for relapsed cases.
Area of Science:
- Pediatric Neurosurgery
- Pediatric Oncology
- Neuro-oncology
Background:
- Medulloblastoma is a common malignant brain tumor in children.
- Optimal treatment strategies require balancing efficacy with long-term sequelae.
Purpose of the Study:
- To evaluate treatment outcomes for pediatric medulloblastoma.
- To analyze the impact of surgical resection, radiotherapy, and chemotherapy on survival and sequelae.
Main Methods:
- Retrospective analysis of 20 pediatric medulloblastoma cases treated over 6 years.
- Evaluation of surgical techniques (radical vs. subtotal resection), radiotherapy doses, and chemotherapy regimens.
- Assessment of postoperative mortality, survival rates, and treatment-related sequelae.
Main Results:
- Postoperative mortality was 5%; 3-year and 5-year survival rates were 40% and 25%, respectively.
- Radical resection was associated with improved prognosis.
- Lower-dose radiotherapy appeared to reduce neuropsychological and endocrinological sequelae.
- Combination chemotherapy demonstrated higher efficacy in relapsed cases compared to monochemotherapy.
Conclusions:
- Radical tumor resection is a critical factor for better medulloblastoma outcomes in children.
- Tailoring radiotherapy doses and chemotherapy protocols based on risk stratification may optimize treatment efficacy and minimize long-term adverse effects.
Abstract:
20 medulloblastomas in children were treated at the Neurosurgical Department of Perugia over the last 6 years. The age ranged between 1.2 and 15 years, with a mean of 8 years. The ratio between males and females was 3/1. Only three tumors were localized within one cerebellar hemisphere. A shunt was performed before the removal of the tumor in 12 cases. Radical resection was completed in 15 cases, whereas a subtotal removal was performed in the cases with involvement of the brain stem. The postoperative mortality rate was 5%. The 3-year survival rate was 40% and the 5-year 25%. The postoperative radiotherapy was given at lower doses than usually reported by other authors: this seems to reduce the neuropsychological and endocrinological sequelae. CCNU of BCNU were given after radiotherapy, but this monochemotherapy seems to be less effective than polychemotherapy with CCNU, vincristine, procarbazine and dexamethasone, used in this series when relapse occurred. Radical resection improved the prognosis. The opportunity of using different protocols for 'low risk' and for 'high risk' patients is finally discussed.